GLMD icon

Galmed Pharmaceuticals
GLMD

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $25M invested in Galmed Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

more ownership

Funds ownership: →

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.66M
2
+$2.16M
3
+$914K
4
JGC
J. Goldman & Co
New York
+$569K
5
Morgan Stanley
Morgan Stanley
New York
+$421K

Top Sellers

1
-$1.36M
2
-$167K
3
-$57K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$5.94M
2
$4.36M
3
$3.66M
4
$2.68M
5
$2.16M
6
$2.08M
7
$1.53M
8
$961K
9
$569K
10
$345K
11
$246K
12
$119K
13
$109K
14
$92K
15
$57K
16
$36K
17
$8K
18
$7K
19
$2K
20
–
21
–
22
–